Evommune, Inc.
EVMN
$24.09
-$0.94-3.76%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
1/19/2026
-
MarketBeat
3/18/2026
-
Yahoo! Finance: News
3/18/2026
-
MarketBeat
3/18/2026
-
Benzinga
3/18/2026
-
TipRanks Financial Blog
3/17/2026
-
TipRanks Financial Blog
3/16/2026
-
MarketBeat
3/10/2026
-
Fool.com Headlines
3/9/2026
-
MarketBeat
3/7/2026
-
Simply Wall St
3/6/2026
-
MarketBeat
3/6/2026
-
Ticker Report
3/6/2026
-
MarketBeat
3/6/2026
-
TipRanks Financial Blog
3/6/2026
-
TipRanks Financial Blog
3/6/2026
-
Nasdaq News: Markets
3/5/2026
-
TipRanks Financial Blog
3/5/2026
-
The Fly
3/5/2026
-
The Fly
3/5/2026
-
Business Wire
2/26/2026
-
MarketBeat
2/19/2026
-
MarketBeat
2/18/2026
-
TipRanks Financial Blog
2/18/2026
-
TipRanks Financial Blog
2/18/2026
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 5, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Jul 13 and 17 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(925) 247-4481
Address
1841 Page Mill Road
Palo Alto, CA 94304
Palo Alto, CA 94304
Country
Year Founded
Business Description
Sector
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial...
more